- Research works
- 21 ▼ 37% vs 2013–17
- Citations
- 715 33.9 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 49% world 28%
Not ranked overall: HemoShear (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at HemoShear (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Metabolic Syndrome, Oxidative Stress, Cardiovascular Disease, Insulin Resistance, Immune Response, Hepatic Steatosis and Biochemical Genetics.
- Metabolic Regulation
- Hepatic Stellate Cells
- NAFLD
- Hepatocellular Carcinoma
- Angiogenesis
- Metabolic Disorders
- Insulin Resistance
- Hepatic Steatosis
- Cardiovascular Disease
- Metabolic Syndrome
- Inflammation
- Oxidative Stress
- Epidemiology
- Immune Response
- Biochemical Genetics
- Cell Death
- Atherosclerosis
- Macrophages
- NASH
- Liver Regeneration
- Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 21 words, with their numbers
- Inflammation4▲ 7.4×12 topics
- Metabolic Syndrome3▲ 16×7 topics
- Oxidative Stress3▲ 7.2×4 topics
- Cardiovascular Disease2▲ 7.7×7 topics
- Epidemiology2▲ 2.1×7 topics
- Hepatic Steatosis2▲ 54×2 topics
- Immune Response2▲ 13×4 topics
- Insulin Resistance2▲ 18×3 topics
- Biochemical Genetics2▲ 91×1 topic
- Metabolic Disorders2▲ 38×1 topic
- Cell Death1▲ 32×2 topics
- Angiogenesis1▲ 15×3 topics
- Atherosclerosis1▲ 17×4 topics
- Hepatocellular Carcinoma1▲ 29×2 topics
- Macrophages1▲ 33×2 topics
- NAFLD1▲ 50×1 topic
- NASH1▲ 50×1 topic
- Hepatic Stellate Cells1▲ 211×1 topic
- Liver Regeneration1▲ 211×1 topic
- Metabolic Regulation1▲ 18×2 topics
- Treatment1▲ 3.9×3 topics
Which research topics does HemoShear (United States) publish most on?
By volume in 2022–2025: Metabolism and Genetic Disorders, Liver physiology and pathology, Diet and metabolism studies and Renal cell carcinoma treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Metabolism and Genetic Disorders Clinical Biochemistry 1 works
- 2 Liver physiology and pathology Hepatology 0 works
- 3 Diet and metabolism studies Physiology 0 works
- 4 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
- 5 Musculoskeletal Disorders and Rehabilitation Rehabilitation 0 works
- 6 Sports injuries and prevention Orthopedics and Sports Medicine 0 works
- 7 Musicians’ Health and Performance Rehabilitation 0 works
- 8 Renal and related cancers Molecular Biology 0 works
- 9 Genetic and Kidney Cyst Diseases Genetics 0 works
- 10 Folate and B Vitamins Research Rheumatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has HemoShear (United States)'s research output changed?
Output in 2018–2022 was 37% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Charlottesville
- University of Virginia
- University of Virginia Health System
- National Radio Astronomy Observatory
- University of Virginia Medical Center
- Charlottesville Medical Research
- CFA Institute
- Center for Open Science
- University of Virginia Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.